Suppr超能文献

抗甲状腺治疗前后甲状腺功能亢进症患者的纤维蛋白原及纤溶活性

Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment.

作者信息

Marongiu F, Conti M, Mameli G, Murtas M L, Balzano S, Sorano G, Mamusa A M, Martino E

机构信息

Istituto di Medicina Interna, Università di Cagliari, Italy.

出版信息

J Endocrinol Invest. 1988 Nov;11(10):723-5. doi: 10.1007/BF03350928.

Abstract

Plasma concentration of fibrinogen and B beta 15-42, a specific product of fibrinogen metabolism induced by plasmin, were measured in a group of patients with untreated hyperthyroidism and in controls. Significantly increased plasma levels of both parameters were observed in hyperthyroid patients. The restoration of euthyroidism either by antithyroid drug or by radioiodine caused a significant decrease of fibrinogen and B beta 15-42. These data indicate that hyperthyroidism is another clinical condition associated with increased concentration of fibrinogen and B beta 15-42.

摘要

在一组未经治疗的甲状腺功能亢进患者及对照组中,检测了纤维蛋白原的血浆浓度以及纤溶酶诱导的纤维蛋白原代谢的特定产物Bβ15 - 42。甲状腺功能亢进患者的这两个参数的血浆水平均显著升高。通过抗甲状腺药物或放射性碘使甲状腺功能恢复正常后,纤维蛋白原和Bβ15 - 42显著降低。这些数据表明,甲状腺功能亢进是另一种与纤维蛋白原和Bβ15 - 42浓度升高相关的临床病症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验